Genwi Logo
Join
Login
Pssst! You're viewing a post someone added to Genwi.
Genwi brings you updates from your favorite websites and friends, all in one place.
Learn more…
Public Wire
Lilly to Buy ImClone for $6.5 Billion
The bid by Lilly for the biotechnology company beat out an offer from Bristol-Myers Squibb, which markets ImClones cancer drug Erbitux in the United States along with ImClone.
Read Full Article
Favorite
Share
Email
1 Star
2 Star
3 Star
4 Star
5 Star
Current Rating
Views 2
NYT > Home Page
(add to wire)
on Oct 06, 08
Leave a comment
Post Comment
Get your own personal wire
Sign up
(it's free)
or
Remember Me
Forgot password?
Login with OpenID
Related Items
Eli Lilly to buy ImClone for $6.5 billion (Reuters)
Lilly to acquire ImClone Systems in $6.5 billion transaction (Reuters)
Eli Lilly set to buy ImClone for $6.1 billion: sources (Reuters)
ImClone set to be acquired by Eli Lilly for $6.1 bln: sources (Reuters)
Lilly to Buy ImClone for $6.5 Billion
Bristol offers to buy ImClone for $60 a share (Reuters)
Eli Lilly Agrees to Buy ImClone Systems for $6.5 Billion
Eli Lilly to Buy ImClone for $6.5 Billion
Lilly to Buy ImClone for $6.5 Billion
ImClone says has received $70 share buyout offer (Reuters)
NYT > Home Page
